Peptide record

TPDB26910

Antibacterial Anticancer Antifungal Toxicity modified_plain modified
2 source-reported length (unverified)
Basic Information
TPDB26910
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 2 (unverified).
Modified, details unspecified
Sequence
XP

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
2 source-reported length (unverified)
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
Toxicity
>100 µM
Cytotoxic
IC50 | >100 | µM | target cell: Human normal breast epithelial cells fR-2

Target

Human normal breast epithelial cells fR-2

Source & Reference

NA
DBAASP
Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2. | Bioconjug Chem | 2018
Evidence 2 Activity

Activity

IC50
Toxicity
89.9±1.6 µM
Cytotoxic
IC50 | 89.9±1.6 | µM | target cell: Human normal breast epithelial cells fR-2

Target

Human normal breast epithelial cells fR-2

Source & Reference

NA
DBAASP
Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2. | Bioconjug Chem | 2018
Evidence 3 Activity

Activity

IC50
Toxicity
74.3±1.8 µM
Cytotoxic
IC50 | 74.3±1.8 | µM | target cell: Human normal breast epithelial cells fR-2

Target

Human normal breast epithelial cells fR-2

Source & Reference

NA
DBAASP
Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2. | Bioconjug Chem | 2018
Evidence 4 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Bioorg Med Chem Lett. 2012 Jun 15 22(12):3866-9.